LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting MiR-362-5p/CHSY1 Pathway

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2021 Apr 9

PMID 33833527

Citations 10

Authors

Jiandong Li

Xiaohu Xu

Dandan Zhang

Han Lv

Xin Lei

Affiliations

Soon will be listed here.

Abstract

Background: Oral squamous cell carcinoma (OSCC) is a common oral cancer. The current study aims to elucidate the potential roles of long noncoding RNA (lncRNA) LHFPL3-AS1 in OSCC development.

Methods: Gene expression was measured by qRT-PCR in tumor tissues and cell lines. Loss-of-function assays were performed to analyze the effects of LHFPL3-AS1 on malignant behaviors. Bioinformatics analysis was conducted to explore the downstream signaling pathway of LHFPL3-AS1 in OSCC.

Results: LHFPL3-AS1 was highly expressed in OSCC tissues and cell lines. LHFPL3-AS1 was upregulated in cisplatin-resistant tumor cell lines. LHFPL3-AS1 level was correlated with survival rate. LHFPL3-AS1 knockdown suppressed OSCC proliferation, migration and invasion. LHFPL3-AS1 downregulation reduced cisplatin resistance of OSCC cells. LHFPL3-AS1 was the competing endogenous RNA (ceRNA) for miR-194-5p to enhance CHSY1 expression.

Conclusion: LHFPL3-AS1/miR-362-5p/CHSY1 signaling pathway plays essential roles in regulating OSCC development and cisplatin resistance.

Citing Articles

LINC00342 regulates the PI3K-AKT signaling pathway via the miR-149-5p/FGF11 axis and affects the progression of oral cancer.

Chen Y, Wang Y, Zhang W Discov Oncol. 2024; 15(1):606.

PMID: 39480592 PMC: 11528089. DOI: 10.1007/s12672-024-01457-4.

Novel insights on oral squamous cell carcinoma management using long non-coding RNAs.

Sur S, Davray D, Basu S, Kheur S, Pal J, Nagar S Oncol Res. 2024; 32(10):1589-1612.

PMID: 39308526 PMC: 11413828. DOI: 10.32604/or.2024.052120.

Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications.

Dey S, Biswas B, Manoj Appadan A, Shah J, Pal J, Basu S Cancers (Basel). 2023; 15(15).

PMID: 37568568 PMC: 10417002. DOI: 10.3390/cancers15153752.

COX10-AS1-mediated miR-361-5p regulated cell invasion and migration by targeting SPRY1 in oral squamous cell carcinoma.

Deng J, Wu M Am J Transl Res. 2023; 15(3):2191-2206.

PMID: 37056821 PMC: 10086905.

Hsa_circ_0005050 regulated the progression of oral squamous cell carcinoma via miR-487a-3p/CHSY1 axis.

Chen X, Chen Q, Zhao C, Lu Z J Dent Sci. 2023; 18(1):282-294.

PMID: 36643258 PMC: 9831796. DOI: 10.1016/j.jds.2022.05.012.

References

Wang F, Ji X, Wang J, Ma X, Yang Y, Zuo J . LncRNA PVT1 Enhances Proliferation and Cisplatin Resistance via Regulating miR-194-5p/HIF1a Axis in Oral Squamous Cell Carcinoma. Onco Targets Ther. 2020; 13:243-252. PMC: 6957095. DOI: 10.2147/OTT.S232405. View

Li G, Ma Z, Wang X . Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway. Cell Cycle. 2019; 18(21):2902-2913. PMC: 6791703. DOI: 10.1080/15384101.2019.1662257. View

Jie Y, Ye L, Chen H, Yu X, Cai L, He W . ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer. Bioengineered. 2020; 11(1):872-882. PMC: 8291874. DOI: 10.1080/21655979.2020.1797281. View

Xiao S, Song B . LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis. Biosci Rep. 2020; 40(8). PMC: 7426630. DOI: 10.1042/BSR20193287. View

Wei X, Wang B, Wang Q, Yang X, Yang Y, Fang Z . MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI. Front Pharmacol. 2020; 11:164. PMC: 7063466. DOI: 10.3389/fphar.2020.00164. View

Jiang Y, Zhang H, Li W, Yan Y, Yao X, Gu W . FOXM1-Activated LINC01094 Promotes Clear Cell Renal Cell Carcinoma Development via MicroRNA 224-5p/CHSY1. Mol Cell Biol. 2019; 40(3). PMC: 6965037. DOI: 10.1128/MCB.00357-19. View

Li C, Ye J, Zhang Z, Gong Z, Lin Z, Ding M . Long non-coding RNA RBM5-AS1 promotes the aggressive behaviors of oral squamous cell carcinoma by regulation of miR-1285-3p/YAP1 axis. Biomed Pharmacother. 2019; 123:109723. DOI: 10.1016/j.biopha.2019.109723. View

Wu F, Yin C, Qi J, Duan D, Jiang X, Yu J . miR-362-5p promotes cell proliferation and cell cycle progression by targeting GAS7 in acute myeloid leukemia. Hum Cell. 2020; 33(2):405-415. PMC: 7080691. DOI: 10.1007/s13577-019-00319-4. View

Chi A, Day T, Neville B . Oral cavity and oropharyngeal squamous cell carcinoma--an update. CA Cancer J Clin. 2015; 65(5):401-21. DOI: 10.3322/caac.21293. View

10.

Peng Q, Liu L, Pei H, Zhang J, Chen M, Zhai X . A LHFPL3-AS1/miR-580-3p/STAT3 Feedback Loop Promotes the Malignancy in Melanoma via Activation of JAK2/STAT3 Signaling. Mol Cancer Res. 2020; 18(11):1724-1734. DOI: 10.1158/1541-7786.MCR-19-1046. View

11.

Xue F, Cheng Y, Xu L, Tian C, Jiao H, Wang R . LncRNA NEAT1/miR-129/Bcl-2 signaling axis contributes to HDAC inhibitor tolerance in nasopharyngeal cancer. Aging (Albany NY). 2020; 12(14):14174-14188. PMC: 7425502. DOI: 10.18632/aging.103427. View

12.

Sun F, Wu K, Yao Z, Mu X, Zheng Z, Sun M . Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs. Onco Targets Ther. 2020; 13:6755-6765. PMC: 7360424. DOI: 10.2147/OTT.S242441. View

13.

Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008; 45(4-5):309-16. DOI: 10.1016/j.oraloncology.2008.06.002. View

14.

Dai J, Mu J, Mu H . Long non-coding RNA CRNDE regulates cell proliferation, migration, invasion, epithelial-mesenchymal transition and apoptosis in oral squamous cell carcinoma. Oncol Lett. 2019; 17(3):3330-3340. PMC: 6396137. DOI: 10.3892/ol.2019.9978. View

15.

Yamauchi K, Yang M, Hayashi K, Jiang P, Yamamoto N, Tsuchiya H . Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res. 2008; 68(2):516-20. DOI: 10.1158/0008-5472.CAN-07-3063. View

16.

Sun C, Zhang Q, Zheng G, Feng B . Phytochemicals: Current strategy to sensitize cancer cells to cisplatin. Biomed Pharmacother. 2018; 110:518-527. DOI: 10.1016/j.biopha.2018.12.010. View

17.

Zhao J, Bai X, Feng C, Shang X, Xi Y . Long Non-Coding RNA HCP5 Facilitates Cell Invasion And Epithelial-Mesenchymal Transition In Oral Squamous Cell Carcinoma By miR-140-5p/SOX4 Axis. Cancer Manag Res. 2019; 11:10455-10462. PMC: 6913263. DOI: 10.2147/CMAR.S230324. View

18.

Huang W, Cao J, Peng X . LINC01234 facilitates growth and invasiveness of oral squamous cell carcinoma through regulating the miR-637/NUPR1 axis. Biomed Pharmacother. 2019; 120:109507. DOI: 10.1016/j.biopha.2019.109507. View

19.

Gomes C, de Sousa S, Calin G, Gomez R . The emerging role of long noncoding RNAs in oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 123(2):235-241. DOI: 10.1016/j.oooo.2016.10.006. View

20.

He H, Wang Y, Ye P, Yi D, Cheng Y, Tang H . Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020; 39(1):159. PMC: 7427719. DOI: 10.1186/s13046-020-01664-1. View